UnknownNot Applicable

Individualised Gait Modification Strategies in Alkaptonuria Patients

30 participantsStarted 2021-10

Plain-language summary

This study evaluates the efficacy of a gait modification intervention using real-time biofeedback on reducing the knee joint loading in Alkaptonuria patients during treadmill walking. It will also assess whether the individualised adopted gait modification can be retained without feedback and during over ground walking.

Who can participate

Age range

18 Years – 80 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * The diagnosis of Alkaptonuria * Able to understand written and spoken English. * Willing and able to give informed consent to participate * Above the age of 18. Exclusion Criteria: * The reliance on or use of a walking aid. * Any previous lower limb joint replacements. * Any severe pain or unable to walk comfortably and consecutively for 20 minutes. * Pregnant

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Change from baseline 3D knee joint moment impulse after intervention

Timeframe: At baseline and immediately after the intervention

Trial details

NCT IDNCT04142671

SponsorLiverpool John Moores University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-10

Contact for this trial

Hannah H Shepherd

+447711490847 H.R.Shepherd@ljmu.ac.uk

View on ClinicalTrials.gov More Alkaptonuria trials